Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Effect of Silybin on Lipid Profile in Hypercholesterolaemic Rats
Senthil Gobalakrishnan1, Sylvia Santhakumari Asirvatham2, Venkatraman Janarthanam3
1Assistant Professor, Department of Pharmacology, Sri Manakula Vinayagar Medical college , Pondicherry, India .
Insights
Silybin effectively lowered cholesterol and triglycerides in hypercholesterolemic rats. This natural compound shows promise as a hypolipidemic agent, reducing LDL-C and increasing HDL-C levels.
Area of Science:
- Pharmacology
- Biochemistry
- Cardiovascular Research
Background:
- Hyperlipidemia is a primary driver of atherosclerosis and related cardiovascular diseases like Coronary Heart Disease (CHD).
- Existing hypolipidemic drugs necessitate ongoing research for more effective alternatives.
Purpose of the Study:
- To investigate the hypolipidemic effects of Silybin in a rat model of hypercholesterolemia.
- To evaluate Silybin's impact on serum and hepatic lipid profiles.
Main Methods:
- Hypercholesterolemic rats were administered Silybin at doses of 300mg and 600mg for 60 days.
- Plasma and liver biochemical analyses were performed post-fasting.
- Data were statistically analyzed using ANNOVA and Duncan's test (p≤0.05).
Main Results:
- High cholesterol diet significantly elevated serum total cholesterol, triglycerides, LDL-C, and VLDL-C.
- Silybin treatment dose-dependently reduced serum total cholesterol (24%), triglycerides (21%), and LDL-C (24%).
- Silybin increased hepatic HDL-C and decreased other hepatic lipid profiles.
Conclusions:
- Silybin demonstrated significant hypolipidemic effects in hypercholesterolemic rats.
- Both tested doses of Silybin effectively reduced serum and hepatic cholesterol, triglycerides, VLDL-C, and LDL-C.
- Silybin also significantly increased HDL-C levels at both doses.
Introduction:
Hyperlipidemia is a major cause of atherosclerosis and atherosclerosis associated conditions, such as Coronary Heart Disease (CHD), ischaemic cerebrovascular disease and peripheral vascular disease. Though there are hypolipidemic drugs available, the search for a more efficacious hypo lipidemic agent was always going on.
Aim:
To study the effect of Silybin on lipid profile in Hypercholesterolaemic rats.
Materials And Methods:
After grant of permission from animal ethics committee, the animals were divided into four groups of eight each (normal control, Experimental control with High cholesterol diet, High cholesterol diet + Silybin 300mg, High cholesterol diet + Silybin 600mg). At the end of 60 days the animals in all the groups were subjected to overnight fasting followed by plasma and liver biochemical analyses.
Statistical Analysis:
The data were analysed by ANNOVA followed by Duncan's multi range test and the value of p≤0.05 was used as the criterion for statistical significance.
Results:
The rats fed on high cholesterol diet showed significant increase in serum total cholesterol, Triglycerides, LDL-C and VLDL-C. Treatment with Silybin significantly decreased serum total cholesterol (24%), Triglycerides (21%), LDL-C (24%) in a dose dependent manner. Rats treated with Silybin (300 and 600 mg/kg) showed significant increase in hepatic HDL -C and decrease in other lipid profiles.
Conclusion:
Treatment with Silybin significantly decreased both serum and hepatic total cholesterol, triglycerides, VLDL-C, LDL-C and increased HDL-C at both doses.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...